Total Synthesis of Sphingofungin F

Min Li; Anmei Wu

doi:10.1055/s-2006-947333

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2006(18): 2985-2988
DOI: 10.1055/s-2006-947333

LETTER

Total Synthesis of Sphingofungin F

Min Li*^a, Anmei Wu^b
^a Department of Neurosciences, Georgetown University Medical Center, 4000 Reservoir Road NW, Washington, DC 20057, USA
^b Orgchem Technologies Inc., 2201 W. Campbell Park Dr, Chicago, IL 60612, USA
Fax: +1(202)6870617; e-Mail: ml258@georgetown.edu;

Further Information

Publication History

Received 23 March 2006
Publication Date:
04 August 2006 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A stereoselective approach toward sphingofungin F has been realized from l-quebrachitol. This synthesis featured a substrate-controlled asymmetric Michael addition, a regiospecific methylsulfonate elimination to construct the contiguous chiral centers in the target molecule.

Key words

sphingofungin F - total synthesis - Michael addition - l-quebrachitol - Wittig-type reaction

References and Notes

For reviews, see:
1a Hakomori S. In Sphingolipid Biochemistry. Handbook of Lipid Research Vol. 3: Kafner JN. Hakomori S. Plenum; New York: 1983. p.1

PubMed Google Scholar
1b Merrill AH. Sweeley CC. In Biochemistry of Lipids, Lipoproteins and Membranes Vance DE. Vance J. Elsevier Science B. V.; Amsterdam: 1996. p.309

PubMed Google Scholar
1c Hannun YA. Sphingolipid-Mediated Signal Transduction Chapman and Hall; New York NY: 1997.

PubMed Google Scholar
1d Hannum YA. Science 1996, 274: 1855

PubMed Google Scholar
1e Spiegel S. Milstein S. J. Membr. Biol. 1995, 146: 225

PubMed Google Scholar
1f Shayman JA. J. Am. Soc. Nephrol. 1996, 7: 171

PubMed Google Scholar
1g Igarashi Y. J. Biochem. (Tokyo) 1997, 122: 1080

PubMed Google Scholar
1h Ariga T. Jarvis WD. Yu RK. J. Lipid. Res. 1998, 39: 1

PubMed Google Scholar
2a Hannun YA. Loomis CR. Merrill AH. Bell RM. J. Biol. Chem. 1986, 261: 2604

Crossref PubMed Google Scholar
2b Hannun YA. Science 1989, 243: 500

Crossref PubMed Google Scholar
3a Nugent TC. Hudlicky T. J. Org. Chem. 1998, 63: 510

PubMed Google Scholar
3b Kobayashi S. Furuta T. Hayashi T. Nishijima M. Hanada K. J. Am. Chem. Soc. 1998, 120: 908

PubMed Google Scholar
3c Mandala SM. Harris GH. Methods Enzymol. 2000, 311: 335

PubMed Google Scholar
4a VanMiddlesworth F. Dufresne C. Wincott FE. Mosley RT. Wilson KE. Tetrahedron Lett. 1992, 33: 297

Google Scholar
4b VanMiddlesworth F. Giacobbe RA. Lopez M. Garrity G. Bland JA. Bartizal K. Fromtling RA. Polishook J. Zweerink M. Edison AM. Rozdilsky W. Wilson KE. Monaghan RL. J. Antibiot. 1992, 45: 861

Google Scholar
4c Horn WS. Smith JL. Bills GF. Raghoobar SL. Helms GL. Kurtz MB. Marrinan JA. Frommer BR. Thornton RA. Mandala SM. J. Antibiot. 1992, 45: 1692

Google Scholar
5a Fujita T. Inoue K. Yamamoto S. Ikumoto T. Sasaki S. Toyoma R. Yoneta M. Hoshino Y. Okumoto T. J. Antibiot. 1994, 47: 208

Crossref Google Scholar
5b Miyake Y. Kozutsumi Y. Nakamura S. Fujita T. Kawasaki T. Biochem. Biophys. Res. Commun. 1995, 211: 396

Crossref Google Scholar
5c For synthesis of myriocin, see: Oishi T. Ando K. Chida N. Chem. Commun. 2001, 1932 ; and references cited therein

Crossref Google Scholar
6 Zweerink MM. Edison AM. Wells GB. Pinto W. Lester RL. J. Biol. Chem. 1992, 267: 25032 ; and references cited therein

PubMed Google Scholar
7a Trost BM. Lee CB. J. Am. Chem. Soc. 2001, 123: 12191

Crossref Google Scholar
7b Trost BM. Lee CB. J. Am. Chem. Soc. 1998, 120: 6818

Crossref Google Scholar
8a Wang B. Yu X.-M. Lin G.-Q. Synlett 2001, 904

Crossref PubMed Google Scholar
8b Liu D.-G. Wang B. Lin G.-Q. J. Org. Chem. 2000, 65: 9114

Crossref PubMed Google Scholar
9a Nakamura T. Shiozaki M. Tetrahedron 2002, 58: 8779

Crossref Google Scholar
9b Nakamura T. Shiozaki M. Tetrahedron Lett. 2001, 42: 2701

Crossref Google Scholar
10 Oishi T. Ando K. Inomiya K. Sato H. Iida M. Chida N. Org. Lett. 2002, 4: 151

Crossref PubMed Google Scholar
11a Kobayashi S. Furuta T. Hayashi T. Nishijima M. Hanada K. J. Am. Chem. Soc. 1998, 120: 908

Crossref Google Scholar
11b Kobayashi S. Furuta T. Tetrahedron 1998, 54: 10275

Crossref Google Scholar
12 Lee K.-Y. Oh C.-Y. Ham W.-H. Org. Lett. 2001, 4: 4403

Google Scholar
13a Sano S. Kobayashi Y. Kondo T. Takebayashi M. Maruyama S. Fujita T. Nagao Y. Tetrahedron Lett. 1995, 36: 2097

Crossref Google Scholar
13b Payette DR. Just G. Can. J. Chem. 1981, 59: 269

Crossref Google Scholar
14 The following reference provides detailed procedures for both the preparation of precursors of both 8 and its regioisomer, and the preparation of the regioisomer of compound 8 from the corresponding precursor. It should be mentioned that the synthesis of 8 was accomplished from its corresponding precursor following the same procedure. See: Qiao L. Hu Y. Nan F. Powis G. Kozikowski AP. Org. Lett. 2000, 2: 115

Crossref PubMed Google Scholar
For recent examples of Wittig and Horner-Wadsworth-Emmons reaction, see:
15a List B. Doehring A. Fonseca MTH. Job A. Torres RR. Tetrahedron 2006, 62: 476

Google Scholar
For reviews, see:
15b Harvey RG. Curr. Org. Chem. 2004, 8: 303

Google Scholar
15c Quan L.-G. Cha J.-K. Chem. Phys. Lipids 2004, 128

Google Scholar
15d Rein T. Vares L. Kawasaki I. Pedersen TM. Norrby P.-O. Brandt P. Tanner D. Phosphorus, Sulfur Silicon Relat. Elem. 1999, 144-146: 169

Google Scholar
16a Cardillo G. Simone AD. Gentilucci L. Sabatino P. Tomasini C. Tetrahedron Lett. 1994, 35: 5051

Crossref Google Scholar
16b Trost BM. Dake GR. J. Org. Chem. 1997, 62: 5670

Crossref Google Scholar
16c Krawczyk H. Synth. Commun. 2000, 30: 1787

Crossref Google Scholar
18a Paulsen H. Heiker FR. Angew Chem., Int. Ed. Engl. 1980, 19: 904

Crossref Google Scholar
18b Paulsen H. Heiker FR. Liebigs Ann. Chem. 1981, 2180

Crossref Google Scholar
19 Bartlett PA. Johnson WS. Tetrahedron Lett. 1970, 4459

Crossref Google Scholar
For recent examples of Barton decarboxylation, see:
20a Masterson DS. Porter NA. Org. Lett. 2002, 4: 4253

Google Scholar
20b Elena M. Taddei M. Tetrahedron Lett. 2001, 42: 3519

Google Scholar
20c For a review, see: Barton DHR. Aldrichimica Acta 1990, 23: 3

Google Scholar
21a Gigg J. Gigg R. Payne S. Conant R. J. Chem. Soc., Perkin. Trans. 1 1987, 423

Crossref Google Scholar
21b Vacca JP. de Solms SJ. Huff JR. J. Am. Chem. Soc. 1987, 109: 3478

Crossref Google Scholar
21c Vacca JP. de Solms SJ. Huff JR. Billington BC. Baker R. Kulagowski JJ. Mawer IM. Tetrahedron 1989, 45: 5679

Crossref Google Scholar
23a Bredenkamp MW. Holzapfel CW. Swanepoel AD. Tetrahedron Lett. 1990, 31: 2759

Crossref Google Scholar
23b David S. Hanessian S. Tetrahedron 1985, 41: 643

Crossref Google Scholar
23c Pereyre M. Quintard J.-P. Rahm A. Tin in Organic Synthesis Butterworths; London: 1987. p.261

Crossref Google Scholar
25a Chida N. Yamada L. Suzuki M. Ogawa S. J. Carbohydr. Chem. 1992, 11: 137

Google Scholar
25b Paulsen H. Roeben W. Liebigs Ann. Chem. 1985, 5: 974

Google Scholar

17

Analytical Data of Compound 9.
Amorphous solid, [α]_D ²⁵ +15.6 (c 0.35, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.67-7.85 (m, 4 H), 7.29 (d, J = 8.2 Hz, 2 H), 6.95 (d, J = 8.4 Hz, 2 H), 4.65 (d, J = 11.0 Hz, 2 H), 4.43 (d, J = 4.1 Hz, 1 H), 4.40 (s, 3 H), 4.28 (m, 1 H), 4.19 (d, J = 10.6 Hz, 1 H), 4.07 (dd, J ₁ = 10.2 Hz, J ₂ = 9.0 Hz, 1 H), 3.92 (s, 3 H), 3.65 (dd, J ₁ = 9.6 Hz, J ₂ = 8.8 Hz, 1 H), 2.27 (d, J = 7.4 Hz, 2 H), 1.53 (s, 3 H), 1.49 (s, 3 H), 1.39 (s, 3 H), 1.34 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 171.03, 166.48, 166.50, 159.31, 158.70, 134.57, 134.45, 134.43, 133.63, 131.66, 131.38, 129.89, 129.50, 129.48, 116.45, 110.76, 110.54, 80.02, 79.89, 79.07, 76.75, 75.34, 73.36, 72.16, 71.40, 57.86, 27.33, 27.06, 26.68, 24.65. HRMS: m/z calcd for C₃₁H₃₅NO₁₀: 581.2261; found: 581.2263.

22

Analytical Data of Compound 12.
Amorphous solid, [α]_D ²⁵ +20.3 (c 0.15, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.70-7.88 (m, 4 H), 7.27-7.33 (m, 6 H), 6.86-6.89 (m, 4 H), 6.85 (d, J = 8.3 Hz, 2 H), 4.63-4.68 (m, 6 H), 4.40 (d, J = 3.8 Hz, 1 H), 4.29 (m, 1 H), 3.90 (d, J = 10.6 Hz, 1 H), 3.83 (2 × s, 6 H), 3.80 (s, 3 H), 3.48 (dd, J ₁ = 10.6 Hz, J ₂ = 10.2 Hz, 1 H), 3.45 (dd, J ₁ = 10.6 Hz, J ₂ = 9.8 Hz, 1 H), 1.67 (s, 3 H), 1.36 (s, 3 H), 1.33 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 166.68, 166.50, 159.31, 159.16, 157.35, 138.56, 138.45, 135.46, 135.15, 134.43, 133.10, 131.58, 131.38, 130.73, 129.89, 129.50, 128.55, 128.38, 128.37, 128.00, 127.99, 113.91, 110.89, 83.22, 81.49, 81.28, 76.50, 75.60, 71.73, 69.19, 55.63, 27.35, 25.91.

24

Analytical Data of Compound 6.
Amorphous solid, [α]_D ²⁵ +8.9 (c 0.20, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.74-7.90 (m, 4 H), 7.26-7.33 (m, 6 H), 6.86-6.89 (m, 4 H), 6.85 (d, J = 8.0 Hz, 2 H), 5.31 (s, 1 H), 4.64-4.68 (m, 4 H), 4.64 (d, J = 9.6 Hz, 2 H), 3.86 (d, J = 9.2 Hz, 1 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.46 (dd, J ₁ = 9.6 Hz, J ₂ = 7.8 Hz, 1 H), 3.35 (br s, 1 H), 3.35 (s, 3 H), 1.66 (s, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 165.78, 165.50, 159.31, 159.26, 139.77, 138.85, 138.46, 135.46, 135.02, 134.44, 133.20, 132.66, 131.75, 131.23, 129.89, 129.88, 128.05, 127.98, 127.85, 126.88, 110.91, 110.89, 83.63, 81.62, 81.28, 80.66, 75.81, 75.47, 74.27, 73.97, 55.23, 55.20. HRMS: m/z calcd for C₄₀H₄₁NO₉: 679.2781; found: 679.2785.

26

Analytical Data for Compound 2 (Sphingofungin F).
Amorphous solid, [α]_D ²⁵ +1.33 (c 0.20, MeOH). ¹H NMR (400 MHz, CD₃OD): δ = 5.78 (dt, J ₁ = 15.6 Hz, J ₂ = 6.6 Hz, 1 H), 5.46 (dd, J ₁ = 15.5 Hz, J ₂ = 8.0 Hz, 1 H), 4.11 (t, J = 7.6 Hz, 1 H), 3.86 (br s, 1 H), 3.67 (d, J = 7.5 Hz, 1 H), 2.45 (t, J = 7.5 Hz, 4 H), 2.04-2.06 (m, 2 H), 1.49-1.56 (m, 4 H), 1.48 (s, 3 H), 1.26-1.43 (m, 12 H), 0.90 (t, J = 6.7 Hz, 3 H). ¹³C NMR (100 MHz, CD₃OD): δ = 214.53, 175.32, 135.75, 130.30, 76.25, 75.73, 72.44, 67.03, 43.50, 33.52, 32.79, 30.26, 30.03, 25.02, 23.67, 21.80, 14.43.